Our antibody production services are available as the next step in our service pipeline after antibody discovery or for previously established hybridoma clones.
To schedule antibody production services with the Antibody Technology shared resource, or to get more information about how we can work with you, fill out the inquiry form on our Rates and Scheduling page.
Primary "target-positive" hybridoma clones are archived and the secreted antibodies are analyzed for their performance in specific applications. Once the leads are identified, we carry the primary clones through a subcloning and validation process. These final clones are archived as eight validated subclones from the parental line.
We affinity purify monoclonal antibodies from hybridomas cultured in serum-free media. Our typical threshold for antibody production is 200 mg of research-grade and preclinical material. We currently offer affinity purification at micro (10-80 μg), small, medium (2-25 mg) and large (25-200 mg) scales, or at a custom scale based on your needs.